RT Journal Article
SR Electronic
T1 A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP 20
DO 10.1186/s40425-019-0510-7
VO 7
IS 1
A1 Machiels, Jean-Pascal
A1 Salazar, Ramon
A1 Rottey, Sylvie
A1 Duran, Ignacio
A1 Dirix, Luc
A1 Geboes, Karen
A1 Wilkinson-Blanc, Christine
A1 Pover, Gillian
A1 Alvis, Simon
A1 Champion, Brian
A1 Fisher, Kerry
A1 McElwaine-Johnn, Hilary
A1 Beadle, John
A1 Calvo, Emiliano
YR 2019
UL http://jitc.bmj.com/content/7/1/20.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.